C difficile Infection Four Times More Likely to Kill Patients with Inflammatory Bowel Disease

Article

Clostridium difficile infection is four times more likely to kill patients with inflammatory bowel disease, suggests research published ahead of print in the journal Gut. C difficile is an important cause of diarrhea among inpatients, and the numbers of new cases of the infection have been steadily increasing in recent years.

The findings are based on a representative sample of community hospital admissions in the U.S. for 2003.

The sample covered 994 hospitals in 37 States and included a total of 124,570 patients. Of these, 44,400 had been admitted with C difficile infection, and 77,366 had been admitted with inflammatory bowel disease (Crohns disease or ulcerative colitis), or IBD for short. A further 2,804 had both IBD and C difficile infection. Those with the infection alone tended to be considerably older, and had an average age of 73. Those with IBD had an average age of 42.

The risk of death was higher among those with C difficile infection alone or in combination with IBD than it was in those with IBD alone. But patients with both the infection and IBD were four times more likely to die than patients with just IBD or C difficile infection alone, irrespective of age.

Patients with the combination also stayed in hospital three days longer and had higher rates of endoscopy, a procedure in which a long tube with a camera on the end is passed through the gut. Patients with ulcerative colitis had more severe C difficile infection than those with Crohns disease and worse outcomes.

The authors conclude that patients with IBD may be particularly susceptible to infection with C difficile.

Reference: Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Online First Gut 2007.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.